anti-GD2 monoclonal antibody MORAb-028
Term · Oncology and biomedicine · MLC-T-ONC-010688
A human IgM monoclonal antibody directed against disialoganglioside GD2 with potential immunomodulating activity. Upon administration, anti-GD2 monoclonal antibody MORAb-028 may stimulate the immune system to exert a complement-mediated cytotoxic response against GD2-expressing tumor cells. The glycosphingolipid GD2 is a tumor associated antigen (TAA) overexpressed on the surface of many cancer cells.
| Identifier | MLC-T-ONC-010688 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010688",
"term": "anti-GD2 monoclonal antibody MORAb-028",
"field": "Oncology and biomedicine",
"definition": "A human IgM monoclonal antibody directed against disialoganglioside GD2 with potential immunomodulating activity. Upon administration, anti-GD2 monoclonal antibody MORAb-028 may stimulate the immune system to exert a complement-mediated cytotoxic response against GD2-expressing tumor cells. The glycosphingolipid GD2 is a tumor associated antigen (TAA) overexpressed on the surface of many cancer cells.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-gd2-monoclonal-antibody-morab-028/"
}
Record 1,791 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.